Study shows that Eliquis is safer than Warfarin in Venous Thromboembolism care

July 1 2013 | By Márcio Barra

Pfizer and Bristol-Myers Squibb announced that their blood thinner Eliquis was as good as the Warfarin, the current standard of care, in preventing blood clots, and has a 69% reduction in risk of bleeding complications compared to Warfarin, according to the results of the AMPLIFY study.

View original post 215 more words

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s